Session » Pediatric Rheumatology: Clinical and Therapeutic Disease I: Juvenile Idiopathic Arthritis I
-
Abstract Number: 759
Efficacy and Safety of Canakinumab in Patients with Active Systemic Juvenile Idiopathic Arthritis and Fever: Results From Two Pivotal Phase 3 Trials
-
Abstract Number: 760
Catch-up Growth During Tocilizumab Therapy for Systemic Juvenile Idiopathic Arthritis: 2-Year Data From a Phase 3 Clinical Trial
-
Abstract Number: 761
Analysis of Biomarkers in Systemic Juvenile Idiopathic Arthritis Patients On Canakinumab Therapy
-
Abstract Number: 762
Potentially Fatal Pulmonary Complications in Systemic Juvenile Idiopathic Arthritis
-
Abstract Number: 763
Incidence of Selected Opportunistic Infections Among Children with Juvenile Idiopathic Arthritis
-
Abstract Number: 764
The Impact of Adalimumab On Growth in Patients with Juvenile Idiopathic Arthritis